Global Neurology Academy

The Global Neurology Academy (GNA) series offers certified education modules and video interviews from leading MS experts from across the globe as they address topics such as induction therapy in relapsing-remitting multiple sclerosis; No Evidence of Disease Activity (NEDA) concept; how different agents used in MS management may be utilized in induction therapy; appreciation of how reductions in end-organ damage impact patient quality-of-life; mechanisms of action of the classical as well as emergent agents; key issues associated with making the correct differential diagnosis of multiple sclerosis, in addition to how best to incorporate prognostic indicators into clinical decision-making; current and emergent novel oral agents in MS management; and diagnostic strategies and identifying predictors of outcome.

For more information about GNA, visit www.globalneurologyacademy.org.

403

LikeLikedUnlike

Episodes 76-90 of 183

Emerging Biomarkers for Remyelination in MS: From Fluid Markers to Imaging
NeuroFrontiers
Emerging Biomarkers for Remyelination in MS: From Fluid Markers to Imaging
- Ahmed Abdelhak, MD
  Peer
Anti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
NeuroFrontiers
Anti-Fibrotic ADCs Show Promise in Muscle Preservation for DMD
Collaborative MS Care: Strategies for Empowering Patients and Supporting Brain Health
NeuroFrontiers
Collaborative MS Care: Strategies for Empowering Patients and Supporting Brain Health
- Mary Rensel, MD, FAAN, ABIHM
  Peer
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
NeuroFrontiers
Evaluating Brogidirsen for Exon 44 Skipping in DMD: Early-Phase Insights
Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
NeuroFrontiers
Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
- Maxwell H. Levy, MD
  Peer
Debunking gMG Myths: Counseling Strategies That Change the Conversation
NeuroFrontiers
Debunking gMG Myths: Counseling Strategies That Change the Conversation
- Maxwell H. Levy, MD
  Peer
advertisement
Tremor Relief with a Wearable Device: Exploring an Alternative to Medication and Surgery
NeuroFrontiers
Tremor Relief with a Wearable Device: Exploring an Alternative to Medication and Surgery
- Jerome Lisk, MD, MBA, M.S., FAAN
  Peer
- Emile Maamary
  Peer
- Mark Elias
  Peer
Bridging the Gap: New Consensus Recommendations for Adult DMD Care
NeuroFrontiers
Bridging the Gap: New Consensus Recommendations for Adult DMD Care
- Rosaline Quinlivan
  Peer
- Ryan Quigley
  Peer
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
NeuroFrontiers
Transitioning to Adult Care in DMD: Strategies for Long-Term Support
- Rosaline Quinlivan
  Peer
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
NeuroFrontiers
Supporting Adults With DMD: A Guide to Acute and Long-Term Planning
- Rosaline Quinlivan
  Peer
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
NeuroFrontiers
Investigating Inebilizumab for Generalized Myasthenia Gravis: Results from MINT
- Richard Nowak, MD, MS
  Peer
Reducing the Burden of gMG with a Novel B-Cell Therapy
NeuroFrontiers
Reducing the Burden of gMG with a Novel B-Cell Therapy
- Richard Nowak, MD, MS
  Peer
advertisement
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
NeuroFrontiers
Improving Diagnostic Accuracy in MS: Criteria, Challenges, and Innovations
- Andrew J. Solomon, MD
  Peer
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
On the Frontlines of CIDP
Advancing CIDP Research: Targeted Therapies, AI Integration, and Immunological Insights
- Karissa Gable, MD
  Peer
Enhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
On the Frontlines of Multiple Sclerosis
Enhancing Multiple Sclerosis Care Through Digital Cognitive Assessment
- Mark Gudesblatt, MD
  Peer